The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Castleman Disease: An Update on Classification and the Spectrum of Associated Lesions
Abstract
Since its initial description, researchers have expanded the spectrum of Castleman disease to include not only the classic and well-recognized hyaline-vascular type, but also the plasma cell type and multicentric types of broader histologic range, including human herpes virus-8-associated Castleman disease. These less common subtypes of Castleman disease are less familiar, and may be under-recognized. Also of practical importance, current authors are restructuring the classification of multicentric Castleman disease to accommodate the emerging pathogenic role of human herpes virus-8 and its association with the recently described plasmablastic variant. In addition to an increased risk of lymphoma, patients with Castleman disease also are at increased risk for other related neoplasms, including Kaposi sarcoma and follicular dendritic cell tumors, which are of prognostic and therapeutic relevance. This review focuses on the histologic diagnosis of Castleman disease, current and emerging concepts in its pathogenesis and classification, and associated histopathologic entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Cesarman, E., Chang, Y., Moore, P. S., Said, J. W., & Knowles, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321802 · Cited by 2,818
Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M., Clauvel, J., Raphael, M., Degos, L., et al. (1995) · Blood · doi:10.1182/blood.v86.4.1276.bloodjournal8641276 · Cited by 2,157
Localized mediastinal lymph-node hyperplasia resembling thymoma
Castleman, B., Iverson, L., & Menendez, V. P. (1956) · Cancer · doi:10.1002/1097-0142(195607/08)9:4<822::aid-cncr2820090430>3.0.co;2-4 · Cited by 1,621
Keller, A. R., Hochholzer, L., & Castleman, B. (1972) · Cancer · doi:10.1002/1097-0142(197203)29:3<670::aid-cncr2820290321>3.0.co;2-# · Cited by 1,355
Moore, P. S., & Chang, Y. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321801 · Cited by 1,078
Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease
Yoshizaki, K., Matsuda, T., Nishimoto, N., Kuritani, T., Taeho, L., Aozasa, K., Nakahata, T., Kawai, H., Tagoh, H., & Komori, T. (1989) · Blood · doi:10.1182/blood.v74.4.1360.1360 · Cited by 928 · cited 13×
“The plasma cell type of CD is more commonly multicentric than unicentric, and represents 9% to 24% of localized CD.7,17,18 The localized form occurs in a similar patient population as the hyaline-vascular type18; however, the unicentric plasma cell variant is more likely to be associated with the systemic symptoms and…”
InfluentialPOEMS syndrome: definitions and long-term outcome
Dispenzieri, A., Kyle, R. A., Lacy, M. Q., Rajkumar, S. V., Therneau, T. M., Larson, D. R., Greipp, P. R., Witzig, T. E., Basu, R., Suarez, G. A., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2299 · Cited by 820
Oore, P. A. S. M., & Hang, Y. (1995) · Cited by 667
Dupin, N., Diss, T. L., Kellam, P., Tulliez, M., Du, M.-Q., Sicard, D., Weiss, R. A., Isaacson, P. G., & Boshoff, C. (2000) · Blood · doi:10.1182/blood.v95.4.1406.004k26_1406_1412 · Cited by 647
Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy
Nishimoto, N., Sasai, M., Shima, Y., Nakagawa, M., Matsumoto, T., Shirai, T., Kishimoto, T., & Yoshizaki, K. (2000) · Blood · doi:10.1182/blood.v95.1.56 · Cited by 441
Aoki, Y., Jaffe, E. S., Chang, Y., Jones, K., Teruya-Feldstein, J., Moore, P. S., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.12.4034 · Cited by 427
Oksenhendler, E., Boulanger, E., Galicier, L., Du, M.-Q., Dupin, N., Diss, T. C., Hamoudi, R., Daniel, M.-T., Agbalika, F., Boshoff, C., et al. (2002) · Blood · doi:10.1182/blood.v99.7.2331 · Cited by 411
Frizzera, G., Peterson, B. A., Bayrd, E. D., & Goldman, A. (1985) · Journal of Clinical Oncology · doi:10.1200/jco.1985.3.9.1202 · Cited by 380
Multicentric angiofollicular lymph node hyperplasia: A clinicopathologic study of 16 cases
Weisenburger, D. D., Nathwani, B. N., Winberg, C. D., & Rappaport, H. (1985) · Human Pathology · doi:10.1016/s0046-8177(85)80065-4 · Cited by 376
Multicentric Giant Lymph Node Hyperplasia
Gaba, A. R., Stein, R. S., Sweet, D. L., & Variakojis, D. (1978) · American Journal of Clinical Pathology · doi:10.1093/ajcp/69.1.86 · Cited by 359
Multicentric Castlemanʼs disease in HIV infection: a clinical and pathological study of 20 patients
Oksenhendler, E., Duarte, M., Soulier, J., Cacoub, P., Welker, Y., Cadranel, J., Cazals-Hatem, D., Autran, B., Clauvel, J.-P., & Raphael, M. (1996) · AIDS · doi:10.1097/00002030-199601000-00009 · Cited by 358
Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J.-P., & Agbalika, F. (2000) · Blood · doi:10.1182/blood.v96.6.2069 · Cited by 356
Casper, C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05311.x · Cited by 354
Beck, J. T., Hsu, S.-M., Wijdenes, J., Bataille, R., Klein, B., Vesole, D., Hayden, K., Jagannath, S., & Barlogie, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300904 · Cited by 322
Castleman's disease and related disorders.
Frizzera, G. (1988) · PubMed · Cited by 293
Human herpesvirus 8 encodes a homolog of interleukin-6
Neipel, F., Albrecht, J. C., Ensser, A., Huang, Y. Q., Li, J. J., Friedman-Kien, A. E., & Fleckenstein, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.839-842.1997 · Cited by 292
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
Parravicini, C., Corbellino, M., Paulli, M., Magrini, U., Lazzarino, M., Moore, P. S., & Chang, Y. (1997) · Europe PMC (PubMed Central) · Cited by 286
Frizzera, G., Massarelli, G., Banks, P. M., & Rosai, J. (1983) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198304000-00001 · Cited by 282
Dysregulated interleukin 6 expression produces a syndrome resembling Castleman’s disease in mice
Brandt, S. J., Bodine, D. M., Dunbar, C. E., & Nienhuis, A. W. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114749 · Cited by 248
Multicentric Castleman's disease
Wang, Q. (2000) · Academic Journal of Chinese PLA Medical School · Cited by 234
Interleukin-6 gene expression in Castleman's disease
Leger-Ravet, M., Peuchmaur, M., Devergne, O., Audouin, J., Raphael, M., Van Damme, J., Galanaud, P., Diebold, J., & Emilie, D. (1991) · Blood · doi:10.1182/blood.v78.11.2923.2923 · Cited by 223
Fifty years of multicentric Castleman's disease
Waterston, A., & Bower, M. (2004) · Acta Oncologica · doi:10.1080/02841860410002752 · Cited by 205
Plasmacytoid T cells. Immunohistochemical evidence for their monocyte/macrophage origin.
Facchetti, F., Wolf-Peeters, C. D., Mason, D. Y., Pulford, K. A. F., van den Oord, J. J., & Desmet, V. J. (1988) · PubMed · Cited by 194
Gessain, A., Sudaka, A., Briere, J., Fouchard, N., Nicola, M., Rio, B., Arborio, M., Troussard, X., Audouin, J., & Diebold, J. (1996) · Blood · doi:10.1182/blood.v87.1.414.414 · Cited by 167
Angiofollicular lymph node hyperplasia (Castleman's disease)
McCarty, M. J., Vukelja, S. J., Banks, P. M., & Weiss, R. B. (1995) · Cancer Treatment Reviews · doi:10.1016/0305-7372(95)90034-9 · Cited by 142
Larroche, C., Cacoub, P., Soulier, J., Oksenhendler, É., Clauvel, J., Pietté, J. C., & Raphaël, M. (2002) · American Journal of Hematology · doi:10.1002/ajh.10022 · Cited by 139
Bélec, L., Si‐Mohamed, A., Authier, F., Hallouin, M., Soe, A. M., Cotigny, S., Gaulard, P., & Gherardi, R. K. (1999) · Blood · doi:10.1182/blood.v93.11.3643 · Cited by 135
Lachant, N. A., Sun, N. C. J., Leong, L., Oseas, R. S., & Prince, H. E. (1985) · American Journal of Clinical Pathology · doi:10.1093/ajcp/83.1.27 · Cited by 130
HHV‐8 infection status of AIDS‐unrelated and AIDS‐associated multicentric Castleman's disease
Suda, T., Katano, H., Delsol, G., Kakiuchi, C., Nakamura, T., Shiota, M., Sata, T., Higashihara, M., & Mori, S. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01266.x · Cited by 124
Hanson, C. A., Frizzera, G., Patton, D. F., Peterson, B. A., McClain, K. L., Gajl-Peczalska, K., & Kersey, J. H. (1988) · PubMed · Cited by 117
Nishi, J.-I., Arimura, K., Utsunomiya, A., Yonezawa, S., Kawakami, K., Maeno, N., Ijichi, O., Ikarimoto, N., Nakata, M., Kitajima, I., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01208.x · Cited by 109
Menke, D. M., Tiemann, M., Camoriano, J. K., Chang, S.-F., Madan, A., Chow, M., Habermann, T. M., & Parwaresch, R. M. (1996) · American Journal of Clinical Pathology · doi:10.1093/ajcp/105.3.268 · Cited by 103
Monoclonality and polyclonality of plasma cells in Castleman's disease of the plasma cell variant
Radaszkiewicz, T., Hansmann, M., & Lennert, K. (1989) · Histopathology · doi:10.1111/j.1365-2559.1989.tb02110.x · Cited by 86
Nguyen, D. T., Diamond, L. W., Hansmann, M.-L., Alavaikko, M. J., Schröder, H. C., Fellbaum, C., & FISCHER, R. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb00552.x · Cited by 75
Chadburn, A., Cesarman, E., Nádor, R. G., Liu, Y. F., & Knowles, D. M. (1997) · Cancer · Cited by 74
Dm, M., Camoriano, J. K., & Pm, B. (1992) · PubMed · Cited by 72
Naresh, K. N., Rice, A. J., & Bower, M. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318160ed97 · Cited by 66
Amin, H., Medeiros, L., Manning, J. T., & Jones, D. M. (2003) · American Journal of Surgical Pathology · doi:10.1097/00000478-200301000-00010 · Cited by 53
Multicentric giant lymph node hyperplasia, Kaposi's sarcoma, and lymphoma.
Dickson, D. W., Ben‐Ezra, J. M., Reed, J., Flax, H., & Janis, R. (1985) · PubMed · Cited by 48
Menke, D. M., Chadburn, A., Cesarman, E., Green, E., Berenson, J. R., SAID, J. W., Tiemann, M., Parwaresch, R. M., & Thomé, S. D. (2002) · American Journal of Clinical Pathology · doi:10.1309/7243-av50-kj28-v6j9 · Cited by 45
van Kooten, C., Rensink, I., Aarden, L. A., & Oers, R. H. J. V. (1993) · PubMed · Cited by 39
Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells
Klouche, M., Brockmeyer, N. H., Knabbe, C., & Rose‐John, S. (2002) · AIDS · doi:10.1097/00002030-200205240-00001 · Cited by 38
Skin involvement in giant lymph node hyperplasia (Castleman’s disease)
Kubota, Y., Noto, S., Takakuwa, T., Tadokoro, M., & Mizoguchi, M. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81700-8 · Cited by 31
HHV-8 is not associated with follicular dendritic cell tumours
Nayler, S., Taylor, L. F., & Cooper, K. (1998) · Molecular Pathology · doi:10.1136/mp.51.3.168 · Cited by 22
Cited by
Fajgenbaum, D. C., Uldrick, T. S., Bagg, A., Frank, D., Wu, D., Srkalovic, G., Simpson, D., Liu, A. Y., Menke, D., Chandrakasan, S., et al. (2017) · Blood · doi:10.1182/blood-2016-10-746933 · Cited by 648
van Rhee, F., Wong, R. S., Munshi, N., Rossi, J.-F., Ke, X.-Y., Fosså, A., Simpson, D., Capra, M., Liu, T., Hsieh, R. K., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70319-5 · Cited by 454
Surgery in Castleman's Disease: A Systematic Review of 404 Published Cases
Talat, N., Belgaumkar, A. P., & Schulte, K.-M. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318249dcdc · Cited by 355
Fajgenbaum, D. C., van Rhee, F., & Nabel, C. S. (2014) · Blood · doi:10.1182/blood-2013-12-545087 · Cited by 331
Polizzotto, M. N., Uldrick, T. S., Wang, V., Aleman, K., Wyvill, K. M., Marshall, V., Pittaluga, S., O’Mahony, D., Whitby, D., Tosato, G., et al. (2013) · Blood · doi:10.1182/blood-2013-08-519959 · Cited by 158
Metadata
- Authors
- Cronin, D. M. P., & Warnke, R. A.
- Venue
- Advances in Anatomic Pathology
- Published
- 2009-07
- Volume
- 16
- Issue
- 4
- Pages
- 236-246
- ISSN
- 1072-4109 (ISSN-L)
- OpenAlex
- W2051544229
- Cited by
- 311
- References
- 51
- FWCI
- 8.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.